Ensysce Biosciences Inc. (ENSC)
NASDAQ · Healthcare
Ensysce Biosciences Inc. Shareholder Equity 2020–2025
Ensysce Biosciences Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Ensysce Biosciences Inc. shareholder equity as of December 31, 2025: 3.2M, a 13.34% decrease year-over-year.
- Ensysce Biosciences Inc. shareholder equity for 2025 were 3.2M, a 13.34% decrease from 2024.
- Ensysce Biosciences Inc. shareholder equity for 2024 were 3.7M, a 1248.62% decrease from 2023.
- Ensysce Biosciences Inc. shareholder equity for 2023 were -322,858, a 91.31% decrease from 2022.
- Ensysce Biosciences Inc. shareholder equity for 2022 were -3.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ensysce Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $3 |
| 2024 | $4 |
| 2023 | $-0 |
| 2022 | $-4 |
| 2021 | $-8 |
| 2020 | $-6 |
Ensysce Biosciences Inc. Shareholder Equity — FAQ
Ensysce Biosciences Inc. (ENSC) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENSC's shareholder equity history?
The chart and table above show Ensysce Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.